Matching articles for "Sumavel"
Drugs for Migraine
The Medical Letter on Drugs and Therapeutics • February 13, 2017; (Issue 1514)
An oral nonopioid analgesic may be sufficient for
treatment of mild to moderate migraine without severe
nausea or vomiting. A triptan is the drug of choice for
treatment of moderate to severe migraine. Use...
An oral nonopioid analgesic may be sufficient for
treatment of mild to moderate migraine without severe
nausea or vomiting. A triptan is the drug of choice for
treatment of moderate to severe migraine. Use of
a triptan early in an attack when pain is still mild to
moderate in intensity improves headache response
and reduces recurrence rates.
Comparison Table: Triptans for Migraine (online only)
The Medical Letter on Drugs and Therapeutics • February 13, 2017; (Issue 1514)
...
View the Comparison Table: Triptans for Migraine
A Sumatriptan Patch (Zecuity) for Migraine
The Medical Letter on Drugs and Therapeutics • November 9, 2015; (Issue 1481)
The FDA has approved a sumatriptan iontophoretic
transdermal system (Zecuity – Teva) for acute treatment
of migraine in adults. Sumatriptan, the first
of seven serotonin receptor antagonists...
The FDA has approved a sumatriptan iontophoretic
transdermal system (Zecuity – Teva) for acute treatment
of migraine in adults. Sumatriptan, the first
of seven serotonin receptor antagonists (triptans)
approved for this indication, is the most frequently
prescribed migraine treatment in the US. It is also
available in oral, intranasal, and injectable formulations.